The DMD Hub (Newcastle University), the Cell and Gene Therapy Catapult and the NA-ATTC have collaborated on a project which has resulted in the publication of a white paper Evaluation of the Gene Therapy Patient Referral Pathways in the UK. Neuromuscular teams from six clinical centres shared their experience and provided valuable input into shaping this publication, which looks at both clinical trials and licenced products, and the subsequent proposed patient referral pathways in each of these. Read the full report here.
